Antibody fragment (hinge region, curved)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bd6/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bd6/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bd5/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bd5/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bd4/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bd4/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bd3/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bd3/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bd2/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bd2/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bd1/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bd1/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bd0/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bd0/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bcf/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bcf/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bce/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bce/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bcd/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bcd/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bcc/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bcc/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bcb/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bcb/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bca/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bca/5c264e60c405e91300bc0bc8.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5c264e9cc405e91300bc0bc9/5c264e60c405e91300bc0bc8.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5c264e9cc405e91300bc0bc9/5c264e60c405e91300bc0bc8.png"}]